These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16276519)

  • 21. Kaposi's sarcoma-associated herpesvirus (KSHV): a new viral pathogen associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Said J
    West J Med; 1997 Jul; 167(1):37-8. PubMed ID: 9265864
    [No Abstract]   [Full Text] [Related]  

  • 22. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV).
    Chatlynne LG; Ablashi DV
    Semin Cancer Biol; 1999 Jun; 9(3):175-85. PubMed ID: 10343069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
    Cho HJ; Yu F; Sun R; Lee D; Song MJ
    Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not.
    Quinlivan EB; Zhang C; Stewart PW; Komoltri C; Davis MG; Wehbie RS
    J Infect Dis; 2002 Jun; 185(12):1736-44. PubMed ID: 12085319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Human herpes virus and malignancies].
    Mori S
    Rinsho Byori; 2001 Aug; 49(8):775-8. PubMed ID: 11573285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda.
    Engels EA; Mbulaiteye SM; Othieno E; Gomez M; Mathew S; Cesarman E; Knowles DM; Chadburn A
    Hum Pathol; 2007 Feb; 38(2):308-14. PubMed ID: 17097130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular virology of Kaposi's sarcoma-associated herpesvirus.
    Moore PS; Chang Y
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):499-516. PubMed ID: 11313008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct cellular origins of primary effusion lymphoma with and without EBV infection.
    Hamoudi R; Diss TC; Oksenhendler E; Pan L; Carbone A; Ascoli V; Boshoff C; Isaacson P; Du MQ
    Leuk Res; 2004 Apr; 28(4):333-8. PubMed ID: 15109530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS-related lymphomas: from pathogenesis to pathology.
    Carbone A; Gloghini A
    Br J Haematol; 2005 Sep; 130(5):662-70. PubMed ID: 16115121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma.
    Engels EA; Rosenberg PS; Frisch M; Goedert JJ
    Br J Cancer; 2001 Nov; 85(9):1298-303. PubMed ID: 11720464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human herpesvirus 8 infections in patients with immunodeficiencies.
    Laurent C; Meggetto F; Brousset P
    Hum Pathol; 2008 Jul; 39(7):983-93. PubMed ID: 18570975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiology of AIDS-related Kaposi's sarcoma and lymphoma.
    Boshoff C; Whitby D; Talbot S; Weiss RA
    Oral Dis; 1997 May; 3 Suppl 1():S129-32. PubMed ID: 9456674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Functions and Virus-Host Interactions Implicated in Pathogenesis and Replication of Human Herpesvirus 8.
    Choi YB; Cousins E; Nicholas J
    Recent Results Cancer Res; 2021; 217():245-301. PubMed ID: 33200369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linking KSHV to human cancer.
    Wong EL; Damania B
    Curr Oncol Rep; 2005 Sep; 7(5):349-56. PubMed ID: 16091195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies.
    da Silva SR; de Oliveira DE
    Cancer Lett; 2011 Jun; 305(2):175-85. PubMed ID: 21402436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SIV-positive and SIV-negative rhesus macaques.
    Renne R; Dittmer D; Kedes D; Schmidt K; Desrosiers RC; Luciw PA; Ganem D
    J Med Primatol; 2004 Feb; 33(1):1-9. PubMed ID: 15061726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of human viruses in the pathogenesis of lymphoma.
    Lyons SF; Liebowitz DN
    Semin Oncol; 1998 Aug; 25(4):461-75. PubMed ID: 9728596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology Frontiers in γ-Herpesviruses Treatments.
    Granato M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.